FDA — authorised 30 March 2009
- Application: ANDA090474
- Marketing authorisation holder: APOZEAL PHARMS
- Status: approved
FDA authorised cetrizine on 30 March 2009
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 30 March 2009; FDA has authorised it.
APOZEAL PHARMS holds the US marketing authorisation.